Skip to main content
SpringerLink
Log in

Diagnosis and Management of Autoimmune Salivary Gland Disorders

  • Chapter
Salivary Gland Disorders

  • 3566 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164:1275–1284

    Article  PubMed  Google Scholar 

  2. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888–892

    PubMed  CAS  Google Scholar 

  3. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT (2006) Lymphoma and other malignancies in primary Sjogren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796–803

    Article  PubMed  CAS  Google Scholar 

  4. Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337–2344

    Article  PubMed  Google Scholar 

  5. Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren’s syndrome. Arthritis Rheum 46:741–747

    Article  PubMed  Google Scholar 

  6. Woo SB, Lee SJ, Schubert MM (1997) Graft-vs.-host disease. Crit Rev Oral Biol Med 8:201–216

    PubMed  CAS  Google Scholar 

  7. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A (1996) Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 17:219–224

    PubMed  CAS  Google Scholar 

  8. Sale GE, Shulman HM, Schubert MM, Sullivan KM, Kopecky KJ, Hackman RC, Morton TH, Storb R, Thomas ED (1981) Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 12:1022–1030

    Article  PubMed  CAS  Google Scholar 

  9. Daniels TE, Fox PC (1992) Salivary and oral components of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):571–589

    PubMed  CAS  Google Scholar 

  10. Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, Bootsma H, Kallenberg CG, Spijkervet FK (2007) Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren’s syndrome. Rheumatology 46(2):335–341

    Article  PubMed  CAS  Google Scholar 

  11. Daniels TE (1984) Labial salivary gland biopsy in Sjogren’s syndrome: Assessment as a diagnostic tool criterion in 362 suspected cases. Arthritis Rheum 27(2):147–156

    Article  PubMed  CAS  Google Scholar 

  12. Sreebny L (1992) Saliva-salivary gland hypofunction (SGH). FDI Working Group 10. J Dent Assoc S Afr 47:498–501

    PubMed  CAS  Google Scholar 

  13. Hernandez YL, Lindahl G (1989) Oral candidiasis in Sjogren’s syndrome: Prevalence, clinical correlations and treatment. Oral Surg Oral Med Oral Pathol 68(3):324–329

    Article  PubMed  CAS  Google Scholar 

  14. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcon-Segovia D, Kraus A (1998) Oral manifestations in patients with Sjogren’s syndrome. J Rheumatol 25:906–910

    PubMed  CAS  Google Scholar 

  15. Christensen LB, Petersen PE, Thorn JJ, Schiodt M (2001) Dental caries and dental health behavior of patients with primary Sjogren syndrome. Acta Odontol Scand. 59(3):116–120

    Article  PubMed  CAS  Google Scholar 

  16. Friedlaender MH (1992) Ocular manifestations of Sjogren’s syndrome: Keratoconjunctivitis sicca. Rheum Dis Clin North Am 18(3):591–608

    PubMed  CAS  Google Scholar 

  17. Rogeudas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P (2004) Cutaneous manifestations of primary Sjogren’s syndrome are underestimated. Clin Exp Rheumatol 22:632–636

    Google Scholar 

  18. Provost TT, Watson R (1992) Cutaneous manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):609–616

    PubMed  CAS  Google Scholar 

  19. Alexander E, Provost T (1987) Sjogren’s syndrome. Arch Dermatol 123:801–810

    Article  PubMed  CAS  Google Scholar 

  20. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, Kim DS, Handa T, Izumi T, Mishima M (2005) Pulmonary manifestations of primary Sjogren’s syndrome. A clinical, radiographic and pathologic study. Am J Respir Crit Care Med 171:632–638

    Article  PubMed  Google Scholar 

  21. Constantopoulos SH, Tsianos EV, Moutsopoulos HM (1992) Pulmonary manifestations and gastrointestinal manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):617–635

    PubMed  CAS  Google Scholar 

  22. Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H (1990) Nervous system manifestation in Sjogren’s syndrome. Acta Neurol Scand 81:144–152

    Article  PubMed  CAS  Google Scholar 

  23. Alexander E (1992) Central nervous system disease in Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):637–672

    PubMed  CAS  Google Scholar 

  24. Kaplan MJ, Ike RW (2002) The liver is a common non-exocrine target in primary Sjogren’s syndrome: a retrospective review. BMC Gastroenterol 13(2):21

    Article  Google Scholar 

  25. Edhag O, Helmers C, Samnegard H, Sjogren A, Vallin H (1997) Two cases of myocardial disease simulating constrictive pericarditis. Scand J Thorac Cardiovasc Surg 11(3):225–227

    Google Scholar 

  26. Borda E, Sterin-Borda L (2001) Autoantibodies against neonatal heart M1 muscarinic acetylcholine receptor in children with congenital heart block. J Autoimmun 16(2):143–150

    Article  PubMed  CAS  Google Scholar 

  27. Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, Viola BF, Valzorio B, Mazzucchelli C, Cattaneo R, Scolari F, Maiorca R (2001) Clinical and morphological features of kidney involvement in primary Sjogren’s syndrome. Nephrol Dial Transplant 16(12):2328–2336

    Article  PubMed  CAS  Google Scholar 

  28. Barendregt PJ, Visser MR, Smets EM, Tulen JH, Van den Meiracker AH, Boomsma F, Markusse HM (1998) Fatigue in primary Sjogren’s syndrome. Ann Rheum Dis 57:291–295

    PubMed  CAS  Google Scholar 

  29. Chao NJ (2006) Clinical manifestations of Sjogren’s syndrome. www.uptodate.com

    Google Scholar 

  30. Hsiao M, Schubert MM, Thornquist M (1988) Oral manifestations of acute graft-versus-host disease following marrow transplantation (abstract). J Dent Res 67 (Spec Iss):202

    Google Scholar 

  31. Soares AB, Faria PR, Magna LA, Correa ME, de Sousa CA, Almeida OP, Cintra ML (2005) Chronic GVHD in minor salivary glands and oral mucosa: histopathological and immunohistochemical evaluation of 25 patients. J Oral Pathol Med 34:368–373

    Article  PubMed  CAS  Google Scholar 

  32. Izutsu KT, Sullivan KM, Schubert MM, Truelove EL, Shulman HM, Sale GE, Morton TH, Rice JC, Witherspoon RP, Storb R, Thomas ED (1983) Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 35(5):441–451

    Article  PubMed  CAS  Google Scholar 

  33. Chao NJ (2006) Clinical manifestations and diagnosis of chronic graft-versus-host disease. www.uptodate.com

    Google Scholar 

  34. Schubert MM, Sullivan KM (1990) Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 9:135–43

    PubMed  Google Scholar 

  35. Uderzo C, Fraschinia D, Balduzzi A., Galimberti S, Arrigo G, Biagi E, Pignanelli M, Nicolini B, Rovelli A (1997) Long term effects of bone marrow transplantation on dental status in children with leukemia. Bone Marrow Transplant 20:865–69

    Article  PubMed  CAS  Google Scholar 

  36. Majorana A, Schubert MM, Porta F, Ugazio AG. Sapelli PL (2000) Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management. Support Care Cancer 8:353–65

    Article  PubMed  CAS  Google Scholar 

  37. Berkowitz RJ, Jones P, Barsetti J, Cheung NK, Coccia PF (1987) Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatr Dent 9(2):105–10

    PubMed  CAS  Google Scholar 

  38. Featherstone JD (1999) Prevention and reversal of dental caries: role of low level fluoride. Community Dent Oral Epidemiol 27(1):31–40

    Article  PubMed  CAS  Google Scholar 

  39. Fox PC, Busch KA, Baum BJ (1987) Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 115:581–84

    PubMed  CAS  Google Scholar 

  40. Guggenheimer J, Moore PA (2003) Xerostomia Etiology, Recognition and Treatment. J Am Dent Assoc 134:61–69

    PubMed  Google Scholar 

  41. Atkinson JC, Fox PC (1992) Salivary gland dysfunction. Clin Geriatr Med 8:499–511

    PubMed  CAS  Google Scholar 

  42. Navazesh M (1993) Methods for collecting saliva. Ann N Y Acad Sci 694:72–7

    Article  PubMed  CAS  Google Scholar 

  43. Sreebny LM, Zhu WX (1995) The use of whole saliva in the differential diagnosis of Sjogren’s Syndrome. Adv Dent Res 10:17–24

    Article  Google Scholar 

  44. Baum BJ (1986) Salivary gland function during aging. Gerodontics 2:61–64

    PubMed  CAS  Google Scholar 

  45. Percival RS, Challacombe SJ, Marsh PD (1994) Flow rates of resting whole and stimulated parotid saliva in relation to age and gender. J Dent Res 73:1416–1420

    PubMed  CAS  Google Scholar 

  46. Tishler M, Yaron I, Shirazi I, Yaron M (1997) Saliva: An additional diagnostic tool in Sjogren’s Syndrome. Semin Arthritis Rheum 27:173–9

    Article  PubMed  CAS  Google Scholar 

  47. Atkinson JC (1993) The Role of Salivary Measurements in the diagnosis of salivary autoimmune diseases. Ann N Y Acad Sci 694:238–51

    Article  PubMed  CAS  Google Scholar 

  48. Saito T, Fukuda H, Arisue M, Matsuda A, Shindoh M, Amemiya A, Ohmori K (1991) Relationship between sialographic findings of parotid glands and histopathologic findings of labial glands in Sjogren’s Syndrome. Oral Surg Oral Med Oral Pathol 72:675–80

    Article  PubMed  CAS  Google Scholar 

  49. Silvers AR, Som PM (1998) Salivary glands. Radiol Clin North Am 36:941–66

    Article  PubMed  CAS  Google Scholar 

  50. Wang S, Zou Z, Zhu J (1992) Sequential quantitative scintigraphy of parotid glands with chronic inflammatory diseases. 50:456–65

    CAS  Google Scholar 

  51. Fox PC (1985) Simplified biopsy technique for labial minor salivary glands. Plastic Reconstr Surg 75:592–3

    Article  CAS  Google Scholar 

  52. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558

    Article  PubMed  CAS  Google Scholar 

  53. van der Reijden WA, van der Kwaak JS, Vissink A, Veerman EC, Amerongen AV (1996) Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren’s syndrome. Arthritis Rheum 39:57–63

    Article  PubMed  Google Scholar 

  54. Gravenmade EJ, Vissink A (1993) Mucin-containing lozenges in the treatment of intraoral problems associated with Sjögren’s syndrome. A double-blinded crossover study in 42 patients. Oral Surg Oral Med Oral Pathol 75:466–71

    Article  PubMed  CAS  Google Scholar 

  55. Aagaard A, Godiksen S, Teglers PT Schiodt M, Glenert U (1992) Comparison between new saliva stimulants in patients with dry mouth: a placebo-controlled double-blinded crossover study. J Oral Pathol 21:376–80

    Article  CAS  Google Scholar 

  56. Manthorpe R, Hagen-Petersen S, Prause JU (1984) Primary Sjögren’s syndrome treated with Efamol/Efavit. A doubleblinded cross-over investigation. Rheumatol Int 4:165–7

    Article  PubMed  CAS  Google Scholar 

  57. Theander E, Horrobin DF, Jacobsson LT, Manthorpe R. (2002) Gammalinolenic acid treatment of fatigue associated with primary Sjogren’s syndrome. Scand J Rheumatol 31:72–79

    Article  PubMed  Google Scholar 

  58. Brennan MT, Shariff G, Lockhart PB, Fox PC (2002) Treatment of xerostomia: A systematic review of therapeutic trials. Dent Clin North Am 46(4):847–856

    Article  PubMed  Google Scholar 

  59. von Bültzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B, Fujibayashi T, Navazesh M, Rhodus NL, Schiødt M (2007) Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103Suppl:S57:e1–15

    Google Scholar 

  60. Fox PC, Cummins MJ, Cummins JM (2002) A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjogren’s syndrome. J Altern Complement Med 8(5):651–659

    Article  PubMed  Google Scholar 

  61. Steller M, Chou L, Daniels TE (1988) Electrical stimulation of salivary flow in patients with Sjögren’s syndrome. J Dent Res 67:1334–1337

    PubMed  CAS  Google Scholar 

  62. Talal N, Quinn JH, Daniels TE (1992) The clinical effects of electrostimulation on salivary function of Sjögren’s syndrome patients. A placebo controlled study. Rheumatol Int 12:43–45

    Article  PubMed  CAS  Google Scholar 

  63. Hargitai IA, Sherman RG, Strother JM (2005) The effects of electrostimulation on parotid saliva flow: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99(3):316–320

    Article  PubMed  Google Scholar 

  64. Strietzel FP, Martin-Granizo R, Fedele S, Lo Russo L, Mignogna M, Reichart PA, Wolff A (2007) Electrostimulating device in the management of xerostomia. Oral Dis 13:206–213

    Article  PubMed  CAS  Google Scholar 

  65. Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salis-bury PL 3rd, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: A randomized placebocontrolled fixed-dose multicenter trial. Arch Intern Med 159:174–181

    Article  PubMed  CAS  Google Scholar 

  66. Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY (2002) Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial. Arch Intern Med 162(11):1293–1300

    Article  PubMed  CAS  Google Scholar 

  67. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46(3):748–754

    Article  PubMed  CAS  Google Scholar 

  68. Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC (2004) Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren’s syndrome. Arthritis Rheum 51(4):601–604

    Article  PubMed  CAS  Google Scholar 

  69. Drosos AA, van Vliet-Dascalopoulou E, Andonopoulos AP, Galanopoulou V, Skopouli FN, Moutsopoulos HM (1988) Nandrolone decanoate (deca-durabolin) in primary Sjogren’s syndrome: a double blind pilot study. Clin Exp Rheumatol 6(1):53–57

    PubMed  CAS  Google Scholar 

  70. Fox PC, Datiles M, Atkinson JC, Macynski AA, Scott J, Fletcher D, Valdez IH, Kurrasch RH, Delapenha R, Jackson W (1993) Prednisone and piroxicam for treatment of primary Sjögren’s syndrome. Clin Exp Rheumatol 11:149–156

    PubMed  CAS  Google Scholar 

  71. Price EJ, Rigby SP, Clancy U, Venables PJ (1998) A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren’s syndrome. J Rheumatol 25:896–899

    PubMed  CAS  Google Scholar 

  72. Kruize AA, Hene RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, Bijlsma JW (1993) Hydroxychloroquine treatment for primary Sjögren’s syndrome: a two year double blind crossover trial. Ann Rheum Dis 52:360–364

    Article  PubMed  CAS  Google Scholar 

  73. Ship JA, Fox PC, Michalek JE, Cummins MJ, Richards AB (1993) Treatment of primary Sjögren’s syndrome with lowdose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN protocol study group. J Interferon Cytokine Res 19:943–951

    Article  Google Scholar 

  74. Cummins MJ, Papas A, Kammer GM, Fox PC (2003) Treatment of primary Sjogren’s syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum 49:585–593

    Article  PubMed  CAS  Google Scholar 

  75. Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puechal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J (2004) Inefficacy of infliximab in primary Sjogren’s syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren’s Syndrome (TRIPSS). Arthritis Rheum 50(4):1270–1276

    Article  PubMed  CAS  Google Scholar 

  76. Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR (2004) Etanercept in Sjogren’s syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 50(7):2240–2245

    Article  PubMed  CAS  Google Scholar 

  77. Pillemer SR, Leakan RA, Sankar V, Manny J, Baum BJ, Smith J, Chaudhry U, Fox PC, Radfar L, Ligier S, Brennan MT (2004) Prominent adverse effects of thalidomide in primary Sjogren’s syndrome. Arthritis Rheum 51(3):505–506

    Article  PubMed  Google Scholar 

  78. Moutsopoulos NM, Angelov N, Sankar V, Leakan RA, Pillemer S, Wahl SM (2006) Immunological consequences of thalidomide treatment in Sjogren’s syndrome. Ann Rheum Dis 65(1):112–114

    Article  PubMed  CAS  Google Scholar 

  79. Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H (2005) Rituximab treatment in patients with primary Sjogren’s syndrome: an open-label phase II study. Arthritis Rheum 52(9):2740–2750

    Article  PubMed  CAS  Google Scholar 

  80. Gescuk B, Wu AJ, Whitcher JP, Daniels TE, Lund S, Fye K, Davis JC Jr (2005) Lamivudine is not effective in primary Sjogren’s syndrome. Ann Rheum Dis 64(9):1326–1330

    Article  PubMed  CAS  Google Scholar 

  81. Stevenson D, Tauber J, Reis BL (2000) Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 107(5):967–974

    Article  PubMed  CAS  Google Scholar 

  82. Tsifetaki N, Kitsos G, Paschides CA, Alamanos Y, Eftaxias V, Voulgari PV, Psilas K, Drosos AA (2003) Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren’s syndrome: a randomised 12 week controlled study. Ann Rheum Dis 62(12):1204–1207

    Article  PubMed  CAS  Google Scholar 

  83. Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, Tsubota K (2004) Therapeutic effect of cevimeline on dry eye in patients with Sjogren’s syndrome: a randomized, double-blind clinical study. Am J Ophthalmol 138(1):6–17

    Article  PubMed  CAS  Google Scholar 

  84. Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G (2005) Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjogren’s syndrome patients. Invest Ophthalmol Vis Sci 46(12):4474–4479

    Article  PubMed  Google Scholar 

  85. Zakrzewska JM, Forssell H, Glenny AM (2005) Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 25(1):CD002779

    Google Scholar 

  86. Steinberg S (2002) A paradigm shift in the treatment of caries. Gen Dent 50(4):333–338

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 6509 Seven Locks Road, Cabin John, MD, 20818, USA

    Philip C. Fox DDS

  2. Department of Oral Medicine, Carolinas Medical Center, P.O. Box 32861, Charlotte, NC, 28232, USA

    Catherine H. Hong BDS, MS (Section Head of Pediatric Dentistry) & Andre G. Brun DMD (Resident)

  3. Sjögren’s Syndrome and Salivary Disorders Center, Department of Oral Medicine, Carolinas Medical Center, PO Box 32861, Charlotte, NC, 28232, USA

    Michael T. Brennan DDS, MHS (Oral Medicine Residency Director)

Authors
  1. Philip C. Fox DDS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine H. Hong BDS, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andre G. Brun DMD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael T. Brennan DDS, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Otolaryngology, University of Pittsburgh, School of Medicine The Eye & Ear Institute, Suite 519, 200 Lothrop Street, Pittsburgh, PA, 15213, USA

    Eugene N. Myers MD, FACS, FRCS Edin (Hon) (Distinguished Professor and Emeritus Chair) (Distinguished Professor and Emeritus Chair)

  2. Department of Otolaryngology and of Immunology, University of Pittsburgh, School of Medicine, Pittsburgh

    Robert L. Ferris MD, PhD, FACS (Associate Professor, Chief and Co-Leader) (Associate Professor, Chief and Co-Leader)

  3. Cancer Immunology Program, University of Pittsburgh Cancer Institute, 200 Lothrop Street, Suite 500, Pittsburgh, PA, 15213, USA

    Robert L. Ferris MD, PhD, FACS (Associate Professor, Chief and Co-Leader) (Associate Professor, Chief and Co-Leader)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fox, P.C., Hong, C.H., Brun, A.G., Brennan, M.T. (2007). Diagnosis and Management of Autoimmune Salivary Gland Disorders. In: Myers, E.N., Ferris, R.L. (eds) Salivary Gland Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-47072-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-47072-4_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-47070-0

  • Online ISBN: 978-3-540-47072-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation